(relates to chapter 10, “pain,” in the textbook) copyright © 2011, 2007 by mosby, inc., an...
TRANSCRIPT
(Relates to Chapter 10, “Pain,” in the textbook)
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
2
One major reason people seek health care.
Nurses have a central role in assessment and management.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
3
Assess pain and communicate with other health care providers.
Ensure initiation of adequate pain relief measures.
Evaluate effectiveness of interventions.
Advocate for those in pain.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
4
25 million people experience acute pain from injury or surgery.
50 million people have back pain, arthritis, and migraine headaches.
75% of cancer patients experience significant pain.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
5
Despite the prevalence of pain, many studies document inadequate pain management across care settings and patient populations.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
6
Consequences of untreated pain Unnecessary suffering Physical and psychosocial dysfunction
Impaired recovery from acute illness and surgery
Immunosuppression Sleep disturbances
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
7
Why pain is undertreated Inadequate skills to assess and treat pain
Unwillingness to believe patient reports
Lack of time, expertise, and perceived importance of pain assessments
False concepts of addiction and tolerance
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
8
Whatever the person experiencing pain says it is
Unpleasant sensory and emotional experience associated with actual or potential tissue damage
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
9
Subjective: Patient’s experience and self-report are essential. Can be problematic when dealing with special populations (coma or dementia)
Nonverbal information such as on behaviors aids the assessment of pain.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
10
Multidimensional experience Physiologic Affective Cognitive Behavioral Sociocultural
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
11
Affective (emotions, suffering)
Behavioral (behavioral responses)
Cognitive (beliefs, attitudes, evaluations, goals)
Physiologic (transmission of nociceptive stimuli)
Sensory (pain perception)
PAINPAIN
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
12
Genetic, anatomic, and physical determinants Influence how stimuli are recognized and described
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
13
Emotional response to pain experience Anger Fear Depression Anxiety
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
14
Suffering: State of severe distress associated with loss Eased by pain relief Influenced by spirituality
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
15
Studies demonstrate a link between depression and pain. Treating one can relieve the symptoms of the other.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
16
Observable actions used to express or control pain Facial expressions Socially withdrawn Less physically active Using relaxation Taking medication
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
17
Beliefs, attitudes, memories, and meaning attributed to pain
Influence response to pain and must be incorporated into the comprehensive treatment plan
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
18
Include demographics, support systems, social roles, and culture Age, gender, and education influence beliefs and coping strategies.
Must be assessed without stereotyping
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
19
Nociception: Physiologic process that communicates tissue damage to the CNS Involves four processes•Transduction•Transmission•Perception•Modulation
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
20Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Fig. 10-1. Nocioceptive pain originates when the tissue is injured. 1, Transduction occurs when there isrelease of chemical mediators. 2, Transmission involves the conduct of the action potential from theperiphery (injury site) to the spinal cord and then to the brainstem, thalamus, and cerebral cortex. 3,Perception is the conscious awareness of pain. 4, Modulation involves signals from the brain going backdown the spinal cord to modify incoming impulses.
21
Conversion of a mechanical, thermal, or chemical stimulus into a neuronal action potential Occurs at the nociceptors
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
22
Noxious stimuli cause release of a “biologic soup” of chemicals. These substances activate nociceptors and lead to generation of an action potential carried to the spinal cord.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
23
Inflammation increases the likelihood of transduction. Peripheral sensitization
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
24
Two types of pain Nociceptive•Activation of peripheral nociceptors
Neuropathic•Abnormal processing of stimuli by the nervous system
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
25
Therapy alters local environment or sensitivity of peripheral nociceptors. Prevents transduction and initiation of an action potential
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
26
Process by which pain signals are relayed from the periphery to the spinal cord and then to the brain
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
27
Three segments are involved: Transmission along peripheral nerve fibers to spinal cord
Dorsal horn processing Transmission to thalamus and cerebral cortex
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
28
See Notes.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
29
Spinal Dermatomes
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
eFig. 10-1. Spinal dermatomes representing organized sensory input carried via specific spinal nerveroots. C, Cervical; L, lumbar; S, sacral; T, thoracic.
30
Occurs when pain is recognized, defined, and responded to
Nociceptive input is perceived as pain in the brain.
There is no precise, known location where pain perception occurs.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
31
Activation of descending pathways that exert inhibitory or facilitatory effects on the transmission of pain
Can occur at periphery, spinal cord, brainstem, and cerebral cortex
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
32
By underlying pathology Nociceptive Neuropathic
By duration Acute Chronic
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
33
Damage to somatic or visceral tissue Surgical incision, broken bone, or arthritis•Usually responsive to opioids and nonopioid medications
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
34
Superficial or deepLocalizedArises from bone, joint,
muscle, skin, or connective tissue
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
35
Tumor involvement or obstruction
Arises from internal organs such as the intestine and bladder
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
36
Damage to peripheral nerve or CNS
Numbing, hot-burning, shooting, stabbing, or electrical in nature
Sudden, intense, short-lived, or lingering
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
37
Deafferentation Injury to the peripheral or central nervous system
Sympathetically maintained Dysregulation of the autonomic nervous system
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
38
Painful polyneuropathies Felt along distribution of many peripheral nerves
Painful mononeuropathies Associated with a known peripheral nerve injury and felt along distribution of damaged nerve
Complex regional pain syndromeCopyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
39
Differences based on Cause Course Manifestation Treatment
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
40
Sudden onsetLess than 3 months time for
normal healing to occurMild to severe Generally a precipitating
event or illness can be identified
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
41
Course of pain decreases over time and goes away as recovery occurs
Includes postoperative, labor, and trauma pain
Treatment goal Pain control with eventual elimination
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
42
Manifestations reflect sympathetic nervous system activation: Increased heart rate Increased respiratory rate Increased blood pressure
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
43
Gradual or sudden onsetLess than 3 month duration;
may start acute but continues past normal recovery time
Cause may be unknown.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
44
Does not go away; characterized by periods of waxing and waning
Behavioral manifestations Decreased physical movement/activity
Fatigue Withdrawal from others and social interaction
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
45
Can be disabling and accompanied by anxiety and depression
Treatment goals Control to the extent possible Focus on enhancing function and quality of life
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
46
Nurse is often responsible to Gather and document data Make collaborative decisions with patient and other health care providers
Consider pain the “fifth vital sign.”
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
47
Goals Describe experience to treat. Identify goal for therapy and resources for self-management.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
48
Elements (multidimensional) Direct interview Observation Diagnostic studies Physical examination
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
49
OnsetDurationAssociated
symptomsFactors
increasing or relieving pain
PatternLocation IntensityQuality
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
50
Pain Assessment: Pain Pattern
Pain onset May be unidentifiable
Pain durationPain may be constant or
intermittent.Incident pain
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
51
Pain Assessment: Characteristics
Breakthrough pain Transient, moderate to severe Occurs beyond treated pain Usually rapid onset and brief duration with variable frequency and intensity
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
52
Pain Assessment: Location
Area of pain Location assists in identifying cause and treatment.•Localized•All over•Referred or radiated from origin to different site
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
53Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Fig. 10-2. Typical areas of referred pain.
54
Pain Assessment: Intensity
Intensity of pain Reliable measure for determining treatment
Rated using scales •0 to 10•Use observational skills for nonverbal patients.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
55Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Fig. 10-3. Pain thermometer scale. The patient is asked to circle words next to the thermometeror to mark the area on the thermometer to indicate the intensity of pain.
56
Pain quality Nature or characteristics•Sharp, aching, burning, numbing, stabbing, electric shock–like, throbbing
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
57
Associated symptoms Can worsen pain•Anxiety•Fatigue•Depression
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
58
Management Inquire about strategies used. •Effective and ineffective
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
59
• Follow principles of assessment.
• Every patient deserves adequate pain management.
• Treatment based on patient’s goals
• Use drug and nondrug therapies.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
60
• Use a multimodal approach.• Use a multidisciplinary
approach.• Evaluate effectiveness.• Prevent or manage side
effects.• Involve patient and family
teaching through assessment and treatment.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
61
Three categories of medications Nonopioid Opioid Co-analgesic or adjuvant
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
62
Analgesic ceiling Increasing dose above upper limit produces no greater analgesia
Do not produce tolerance or addiction
Many are OTC
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
63
Aspirin and other salicylatesAcetaminophenNSAIDs
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
64
See Notes.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
65Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Fig. 10-4. Arachidonic acid is oxidized by two different pathways: lipoxygenase and cyclooxygenase. Thecyclooxygenase pathway leads to two forms of the enzyme cyclooxygenase: COX-1 and COX-2. COX-1 is knownas “constitutive” (always present) and COX-2 is known as “inducible” (meaning its expression varies markedlydepending on the stimulus). NSAIDs differ in their actions, with some having more effects on COX-1 and othersmore on COX-2. Indomethacin acts primarily on COX-1, whereas ibuprofen is equipotent on COX-1 and COX-2.Celecoxib primarily inhibits COX-2.
66
Bind to receptors in the CNS Inhibition of transmission of nociceptive input
Altered limbic activity Activation of descending inhibitory pathways
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
67
Pure agonists Morphine, oxycodone, and codeine•Potent, no analgesic ceiling, and have several routes for administration
•Often combined with nonopioid analgesic for relief of moderate pain
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
68
Mixed agonists-antagonists Nalbuphine, pentazocine, butorphanol•Less respiratory depression •More dysphoria and agitation•Have an analgesic ceiling •Can precipitate withdrawal
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
69
Common side effects Constipation (most common) Nausea/vomiting Sedation Respiratory depression Pruritus
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
70
See Notes.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
71
Used in conjunction with opioids and nonopioids
Generally developed for other purposes, but also effective for pain
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
72
CorticosteroidsAntidepressantsAntiseizure drugsGABA receptor agonists
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
73
Adjunct Therapy
α2-Adrenergic agonistsLocal anestheticsMixed mu agonist opioid and
NE/5-HT reuptake inhibitors Cannabinoids
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
74
A patient who has been treated with morphine by patient-controlled analgesia (PCA) is discharged from the hospital with instructions that all of the following medications may be used for pain. Which medication will the nurse instruct the patient to use first?
1. Aspirin 2. Ibuprofen (Motrin, Advil)3. Acetaminophen (Tylenol)4. Oxycodone/acetaminophen (Percocet)
Audience Response Question
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
75
Scheduling Focus on prevention or control. Do not wait for severe pain. Constant pain requires around-the-clock administration (not PRN).
Fast-acting drugs for breakthrough
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
76
Titration Dose adjustment based on assessment of analgesic effect versus side effects
Use the smallest dose to provide effective pain control with fewest side effects.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
77
Administration
Equianalgesic dosing Dose of one analgesic that is equivalent in pain-relieving effects compared with another analgesic
Permits substitution of analgesics in the event that a particular drug is ineffective or causes intolerable side effects
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
78
Benefits of variable routes Target a particular source Achieve therapeutic blood levels rapidly
Avoid certain side effects Provide analgesia when patients cannot swallow
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
79
Oral Route of choice with functioning GI tract
Sublingual and buccal Exempts drug from first-pass effect
IntranasalRectal
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
80
See Notes.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
81
Transdermal Parenteral routes
IM, SC, and IV Intraspinal delivery
Highly potent (smaller doses necessary)
Implantable pumpsPatient-controlled analgesia
(PCA)Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
82
See Notes.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
83
See Notes.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
84
Spinal Anatomy
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Fig. 10-5. Spinal anatomy. The spinal cord extends from the foramen magnum to the first or second lumbarvertebral space. The subarachnoid space (intrathecal space) is filled with cerebrospinal fluid that continuallycirculates and bathes the spinal cord. The epidural space is a potential space filled with blood vessels, fat, and anetwork of nerve extensions.
85
Nerve blocks Interrupt all afferent and efferent transmission, not only nociceptive input
Used during and after surgery to manage pain
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
86
Neuroablative techniques For severe pain unresponsive to other therapy
Destroy nerves to stop transmission
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
87Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Fig. 10-6. Sites of neurosurgical procedures for pain relief.
88
Neuroaugmentation Electrical stimulation of brain and spinal cord
Commonly used for chronic back pain
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
89
Reduces dose of analgesic required and minimizes side effects
Possibly alters ascending nociceptive input or stimulates descending pain modulation mechanisms
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
90
MassageExerciseTENS or PENSAcupunctureHeat or cold therapy
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
91
See Notes.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
92
TENS Treatment
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Fig. 10-7. Initial TENS treatment being given by a physical therapist to assessvalue in pain relief.
93
Cognitive therapies Distraction Hypnosis Imagery Relaxation
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
94
Effective communication Patient’s report of pain is believed, is not perceived as “complaining.”
The nurse communicates concern and affirms her commitment to the patient.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
95
The nurse’s role in analgesic titration for a postoperative patient is:1. Monitoring the effects of continuous infusion of opioid analgesics.2. Determining with the patient the dosage of analgesic required for pain relief. 3. Teaching the patient to try to increase the time between doses of pain medication.4. Assisting the patient to plan the distribution of a specific total dose of analgesic over a 24-hour period.
Audience Response Question
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
96
Common concerns Tolerance Physical dependence Addiction
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
97
Tolerance Need for increased dose to maintain same degree of pain control
Not as common as was once thought
Rotate drug if tolerance develops, as increasing dose could contribute to hyperalgesia.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
98
Physical dependence Expected response to ongoing exposure to pharmacologic agents manifested by withdrawal syndrome when blood levels drop abruptly
To avoid withdrawal, drug should be tapered.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
99
Addiction Neurobiologic condition with drive to obtain and take substances for other than prescribed therapeutic value
Tolerance and physical dependence are not indicators of addiction.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
100
Inadequate health care provider education Curriculum does not include education on pain.
Not a priority in clinical education
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
101
Fear of hastening death by administering analgesics
Requests for assisted suicideUse of placebo in pain
assessment and treatment
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
102
Chronic pain is a problem associated with physical disability and psychosocial problems.
50% to 80% of older adults are estimated to have chronic pain problems.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
103
Most common painful conditions Musculoskeletal •Osteoarthritis •Low back pain•Previous fracture sites
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
104
Chronic pain often results in Depression Sleep disturbance Decreased mobility Decreased health care utilization
Physical and social role dysfunction
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
105
Barriers Belief that pain is inevitable for aging
Greater fear of using opioids Use words like aching, soreness, or discomfort instead of pain
High prevalence of cognitive, sensory-perceptual, and motor problems
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
106
Treatment cautions Metabolize drugs more slowly Risk of GI bleeding with NSAIDs Multiple drug use (interactions) Cognitive impairment, ataxia can be exacerbated by analgesics
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
107
When planning care for a 76-year-old patient with chronic low back pain and severe cervical arthritis, the nurse recognizes that chronic pain in the older adult:1. Is better tolerated than in younger patients.2. Is often seen as an inevitable part of aging.3. Does not require the use of opioids for pain control. 4. Is poorly tolerated because of past experiences with pain.
Audience Response Questions
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
108
Behavioral and physiologic changes may be indicators of pain.
Scales to assess pain in cognitively impaired are based on common behavioral indicators: Facial expressions Breathing Body movement or tension
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
109
Assessing and providing relief with a dual diagnosis of pain and substance abuse is challenging. These patients still have a right to receive effective pain management.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
110
Comprehensive pain assessment Detailed history Physical examination Psychosocial assessment Diagnostic workup
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
111
Establish a treatment plan that will relieve pain and minimize withdrawal symptoms.
Usually require a multidisciplinary team approach
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 112
113
52-year-old woman is experiencing chronic lumbar pain.
Pain began 2 years ago and has gradually increased.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
She has been using acupuncture for pain management, and it is no longer effective.
She uses a heating pad at night, which provides some relief.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 114
She is a recovering substance abuser who has been sober for 30 years. Because of her history, she has avoided using medication unless absolutely necessary.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 115
116
Imaging studies show degenerative disk disease between L1-L2 and L2-L3.
She is prescribed hydrocodone and is referred for physical therapy.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
117
1. She is concerned about taking hydrocodone because of her history of substance abuse. What should you say to her?
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
118
2. Other than medication and physical therapy, what pain relief options might be discussed?
3. What patient teaching is important for her?
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.